Animal models of narcolepsy: Development, findings and perspectives

Narcolepsy: A Clinical Guide

Volumn , Issue , 2010, Pages 23-37

  Sinton, Christopher M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cataplexy; Dog; Hypersomnolence; Hypocretin; Mouse; Orexin; Sleep attack

Indexed keywords

EID: 84877288925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0854-4_2     Document Type: Chapter

References (75)

1. Gélineau, J.B.E. (1880) De la narcolepsie. Gazette des Hôpitaux (Paris), 53, 626-8.
2. Aldrich, M.S. (1992) Narcolepsy. Neurology, 42, 34-43.
3. Honda, Y. (1988) Clinical features of narcolepsy: Japanese experiences. In Honda, Y., Juji, T. (ed.), HLA in Narcolepsy. Springer-Verlag, Berlin, pp. 24-57.
4. Hishikawa, Y. and Shimizu, T. (1995) Physiology of REM sleep, cataplexy, and sleep paralysis. Adv Neurol, 67, 245-71.
5. Mignot, E. (1998) Genetic and familial aspects of narcolepsy. Neurology, 50, S16-22.
6. Nishino, S., Tafti, M., Reid, M.S., Shelton, J., Siegel, J.M., Dement, W.C. and Mignot, E. (1995) Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy. J Neurosci, 15, 4806-14.
7. Kadotani, H., Faraco, J. and Mignot, E. (1998) Genetic studies in the sleep disorder narcolepsy. Genome Res, 8, 427-34.
8. Sweeney, C.R., Hendricks, J.C., Beech, J. and Morrison, A.R. (1983) Narcolepsy in a horse. J Am Vet Med Assoc, 183, 126-8.
9. Dreifuss, F.E. and Flynn, D.V. (1984) Narcolepsy in a horse. J Am Vet Med Assoc, 184, 131-2.
10. Lunn, D.P., Cuddon, P.A., Shaftoe, S. and Archer, R.M. (1993) Familial occurrence of narcolepsy in miniature horses. Equine Vet J, 25, 483-7.
11. White, E.C. and de Lahunta, A. (2001) Narcolepsy in a ram lamb. Vet Rec, 149, 156-7.
12. Strain, G.M., Olcott, B.M., Archer, R.M. and McClintock, B.K. (1984) Narcolepsy in a Brahman bull. J Am Vet Med Assoc, 185, 538-41.
13. Knecht, C.D., Oliver, J.E., Redding, R., Selcer, R. and Johnson, G. (1973) Narcolepsy in a dog and a cat. J Am Vet Med Assoc, 162, 1052-3.
14. Mitler, M.M. and Dement, W.C. (1974) Cataplectic-like behavior in cats after micro-injections of carbachol in pontine reticular formation. Brain Res, 68, 335-43.
15. Mitler, M.M., Boysen, B.G., Campbell, L. and Dement, W.C. (1974) Narcolepsy-cataplexy in a female dog. Exp Neurol, 45, 332-40.
16. Foutz, A.S., Mitler, M.M., Cavalli-Sforza, L.L. and Dement, W.C. (1979) Genetic factors in canine narcolepsy. Sleep, 1, 413-21.
17. Baker, T.L., Foutz, A.S., McNerney, V., Mitler, M.M. and Dement, W.C. (1982) Canine model of narcolepsy: genetic and developmental determinants. Exp Neurol, 75, 729-42.
18. Cederberg, R., Nishino, S., Dement, W.C. and Mignot, E. (1998) Breeding history of the Stanford colony of narcolep-tic dogs. Vet Rec, 142, 31-6.
19. Baker, T.L. and Dement, W.C. (1985) Canine narcolepsy-cataplexy syndrome: evidence for an inherited mono-aminergic-cholinergic imbalance. In McGinty, D.J., Drucker-Colin, R., Morrison, A.R. and Parmeggiani, P.L. (eds.), Brain Mechanisms of Sleep. Raven, New York, N Y, pp. 199-234
20. Riehl, J., Nishino, S., Cederberg, R., Dement, W.C. and Mignot, E. (1998) Development of cataplexy in genetically narcoleptic Dobermans. Exp Neurol, 152, 292-302.
21. Richardson, G.S., Carskadon, M.A., Flagg, W., Van den Hoed, J., Dement, W.C. and Mitler, M.M. (1978) Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol, 45, 621-7.
22. Nishino, S., Riehl, J., Hong, J., Kwan, M., Reid, M. and Mignot, E. (2000) Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans. Neurosci Res, 38, 437-46.
23. Mitler, M.M. and Dement, W.C. (1977) Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. Electroencephalogr Clin Neurophysiol, 43, 691-9.
24. Lucas, E.A., Foutz, A.S., Dement, W.C. and Mitler, M.M. (1979) Sleep cycle organization in narcoleptic and normal dogs. Physiol Behav, 23, 737-43.
25. Kushida, C.A., Baker, T.L. and Dement, W.C. (1985) Electroencephalographic correlates of cataplectic attacks in narcoleptic canines. Electroencephalogr Clin Neurophysiol, 61, 61-70.
26. Babcock, D.A., Narver, E.L., Dement, W.C. and Mitler, M.M. (1976) Effects of imipramine, chlorimipramine, and fuoxetine on cataplexy in dogs. Pharmacol Biochem Behav, 5, 599-602.
27. Foutz, A.S., Delashaw, J.B., Jr., Guilleminault, C. and Dement, W.C. (1981) Monoaminergic mechanisms and experimental cataplexy. Ann Neurol, 10, 369-76.
28. Delashaw, J.B., Jr., Foutz, A.S., Guilleminault, C. and Dement, W.C. (1979) Cholinergic mechanisms and cataplexy in dogs. Exp Neurol, 66, 745-57.
29. Faull, K.F., Barchas, J.D., Foutz, A.S., Dement, W.C. and Holman, R.B. (1982) Monoamine metabolite concentrations in the cerebrospinal fuid of normal and narcoleptic dogs. Brain Res, 242, 137-43.
30. Mefford, I.N., Baker, T.L., Boehme, R., Foutz, A.S., Ciaranello, R.D., Barchas, J.D. and Dement, W.C. (1983) Narcolepsy: biogenic amine defcits in an animal model. Science, 220, 629-32.
31. Boehme, R.E., Baker, T.L., Mefford, I.N., Barchas, J.D., Dement, W.C. and Ciaranello, R.D. (1984) Narcolepsy: cho-linergic receptor changes in an animal model. Life Sci, 34, 1825-8.
32. George, R., Haslett, W.L. and Jenden, D.J. (1964) A cholin-ergic mechanism in the brainstem reticular formation: induction of paradoxical sleep. Int J Neuropharmacol, 3, 541-52.
33. Bowersox, S.S., Kilduff, T.S., Faull, K.F., Zeller-DeAmicis, L., Dement, W.C. and Ciaranello, R.D. (1987) Brain dop-amine receptor levels elevated in canine narcolepsy. Brain Res, 402, 44-8.
34. Nishino, S., Arrigoni, J., Valtier, D., Miller, J.D., Guilleminault, C., Dement, W.C. and Mignot, E. (1991) Dopamine D2 mechanisms in canine narcolepsy. J Neurosci, 11, 2666-71.
35. Mignot, E., Nishino, S., Sharp, L.H., Arrigoni, J., Siegel, J.M., Reid, M.S., Edgar, D.M., Ciaranello, R.D. and Dement, W.C. (1993) Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholin-ergic systems. J Neurosci, 13, 1057-64.
36. Okura, M., Fujiki, N., Kita, I., Honda, K., Yoshida, Y., Mignot, E. and Nishino, S. (2004) The roles of midbrain and diencephalic dopamine cell groups in the regulation of cataplexy in narcoleptic Dobermans. Neurobiol Dis, 16, 274-82.
37. Reid, M.S., Tafti, M., Nishino, S., Sampathkumaran, R., Siegel, J.M. and Mignot, E. (1996) Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine. Brain Res, 733, 83-100.
38. Honda, K., Riehl, J., Mignot, E. and Nishino, S. (1999) Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected]. Neuroreport, 10, 3111-8.
39. Nishino, S., Mao, J., Sampathkumaran, R. and Shelton, J. (1998) Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online, 1, 49-61.
40. Mignot, E., Guilleminault, C., Bowersox, S., Rappaport, A. and Dement, W.C. (1988) Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy. Brain Res, 444, 184-8.
41. Nishino, S., Fruhstorfer, B., Arrigoni, J., Guilleminault, C., Dement, W.C. and Mignot, E. (1993) Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy. J Pharmacol Exp Ther, 264, 1079-84.
42. Nishino, S., Haak, L., Shepherd, H., Guilleminault, C., Sakai, T., Dement, W.C. and Mignot, E. (1990) Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. J Pharmacol Exp Ther, 253, 1145-52.
43. Reid, M.S., Tafti, M., Geary, J.N., Nishino, S., Siegel, J.M., Dement, W.C. and Mignot, E. (1994) Cholinergic mechanisms in canine narcolepsy-I. Modulation of cataplexy via local drug administration into the pontine reticular formation. Neuroscience, 59, 511-22.
44. Reid, M.S., Siegel, J.M., Dement, W.C. and Mignot, E. (1994) Cholinergic mechanisms in canine narcolepsy-II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy. Neuroscience, 59, 523-30.
45. Reid, M.S., Tafti, M., Nishino, S., Siegel, J.M., Dement, W.C. and Mignot, E. (1994) Cholinergic regulation of cata-plexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors. Sleep, 17, 424-35.
46. Marcadet, A., Gebuhrer, L., Betuel, H., Seignalet, J., Freidel, A.C., Confavreux, C., Billiard, M., Dausset, J. and Cohen, D. (1985) DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immunogenetics, 22, 679-83.
47. Motoyama, M., Kilduff, T.S., Lee, B.S., Dement, W.C. and McDevitt, H.O. (1989) Restriction fragment length polymorphism in canine narcolepsy. Immunogenetics, 29, 124-6.
48. Dean, R.R., Kilduff, T.S., Dement, W.C. and Grumet, F.C. (1989) Narcolepsy without unique MHC class II antigen association: studies in the canine model. Hum Immunol, 25, 27-35.
49. Mignot, E., Wang, C., Rattazzi, C., Gaiser, C., Lovett, M., Guilleminault, C., Dement, W.C. and Grumet, F.C. (1991) Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. Proc Natl Acad Sci USA, 88, 3475-8.
50. Mignot, E., Bell, R.A., Rattazzi, C., Lovett, M., Grumet, F.C. and Dement, W.C. (1994) An immunoglobulin switchlike sequence is linked with canine narcolepsy. Sleep, 17, S68-76.
51. Li, R., Mignot, E., Faraco, J., Kadotani, H., Cantanese, J., Zhao, B., Lin, X., Hinton, L., Ostrander, E.A., Patterson, D.F., and de Jong, P.J. (1999) Construction and characterization of an eightfold redundant dog genomic bacterial artif-cial chromosome library. Genomics, 58, 9-17.
52. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. and Mignot, E. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98, 365-76.
53. de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., 2nd., Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M., and Sutcliffe, J.G. (1998) The hypocretins: hypothalamus-specifc peptides with neuroex-citatory activity. Proc Natl Acad Sci USA, 95, 322-7.
54. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richarson, J.A., Kozlowski, G.P., Wilson, S., Arch, J.R., Buckingham, R.E., Haynes, A.C., Carr, S.A., Annan, R.S., McNulty, D.E., Liu, W.S., Terrett, J.A., Elshourbagy, N.A., Bergsma, D.J., and Yanagisawa, M. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 92, 573-85.
55. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B., and Yanagisawa, M. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 98, 437-51.
56. Siegel, J.M. (1999) Narcolepsy: a key role for hypocretins (orexins). Cell, 98, 409-12.
57. Nishino, S., Ripley, B., Overeem, S., Lammers, G.J. and Mignot, E. (2000) Hypocretin (orexin) defciency in human narcolepsy. Lancet, 355, 39-40.
58. Willie, J.T., Chemelli, R.M., Sinton, C.M., Tokita, S., Williams, S.C., Kisanuki, Y.Y., Marcus, J.N., Lee, C., Elmquist, J.K., Kohlmeier, K.A., Leonard, C.S., Richardson, J.A., Hammer, R.E., and Yanagisawa, M. (2003) Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron, 38, 715-30.
59. Willie, J.T. and Yanagisawa, M. (2007) Lessons from Sleepy Mice: Narcolepsy-Cataplexy and the Orexin Neuropeptide System. In Bassetti, C., Billiard, M. and Mignot, E. (eds.), Narcolepsy and Hypersomnia. Informa Healthcare, New York, pp. 257-78.
60. Burgess, C., Tse, G. and Peever, J. (2008) Dopaminergic modulation of cataplexy in hypocretin-null mice. Sleep, 31(Suppl), A5.
61. Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton, C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M., and Sakurai, T. (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 30, 345-54.
62. Beuckmann, C.T., Sinton, C.M., Williams, S.C., Richardson, J.A., Hammer, R.E., Sakurai, T. and Yanagisawa, M. (2004) Expression of a poly-glutamine- ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci, 24, 4469-77.
63. Mieda, M., Willie, J.T., Hara, J., Sinton, C.M., Sakurai, T. and Yanagisawa, M. (2004) Orexin peptides prevent cata-plexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA, 101, 4649-54.
64. Kisanuki, Y.Y., Chemelli, R.M., Sinton, C.M., Williams, S.C., Richardson, J.A., Hammer, R.E. and Yanagisawa, M. (2000) The role of orexin receptor type-1 (OX1R) in the regulation of sleep. Sleep, 23(Suppl 2), A91.
65. Aldrich, M.S. (1998) Diagnostic aspects of narcolepsy. Neurology, 50, S2-7.
66. Kisanuki, Y.Y., Chemelli, R.M., Tokita, S., Willie, J.T., Sinton, C.M. and Yanagisawa, M. (2001) Behavioral and polysomno-graphic characterization of orexin-1 receptor and orexin-2 receptor double knockout mice. Sleep, 24(Suppl), A22.
67. Mieda, M. and Yanagisawa, M. (2006) Rodent models of narcolepsy- cataplexy. In Nishino, S. and Sakurai, T. (eds.), The orexin/hypocretin system: physiology and pathophysiol-ogy. Humana, Totowa, NJ, pp. 255-66.
68. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., Li, R., Hungs, M., Pedrazzoli, M., Padigaru, M., Kucherlapati, M., Fan, J., Maki, R., Lammers, G.J., Bouras, C., Kucherlapati, R., Nishino, S., and Mignot, E. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med, 6, 991-7.
69. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M. and Siegel, J.M. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27, 469-74.
70. Lin, L., Hungs, M. and Mignot, E. (2001) Narcolepsy and the HLA region. J Neuroimmunol, 117, 9-20.
71. Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T. and Scammell, T.E. (2004) Behavioral state instability in orexin knock-out mice. J Neurosci, 24, 6291-300.
72. Wu, M.F., John, J., Boehmer, L.N., Yau, D., Nguyen, G.B. and Siegel, J.M. (2004) Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J Physiol, 554, 202-15.
73. John, J., Wu, M.F., Boehmer, L.N. and Siegel, J.M. (2004) Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron, 42, 619-34.
74. Saper, C.B., Chou, T.C. and Scammell, T.E. (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci, 24, 726-31.
75. Lu, J., Sherman, D., Devor, M. and Saper, C.B. (2006) A putative fip-fop switch for control of REM sleep. Nature, 441, 589-94.